-
Something wrong with this record ?
Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment
BS. Urbanova, JP. Schwabova, H. Magerova, P. Jansky, H. Markova, M. Vyhnalek, J. Laczo, J. Hort, A. Tomek,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT13319
MZ0
CEP Register
PubMed
29614647
DOI
10.3233/jad-170815
Knihovny.cz E-resources
- MeSH
- Alzheimer Disease diagnostic imaging physiopathology MeSH
- Hemodynamics * MeSH
- Cognitive Dysfunction diagnostic imaging physiopathology MeSH
- Humans MeSH
- Magnetic Resonance Imaging MeSH
- Brain blood supply diagnostic imaging physiopathology MeSH
- Cerebrovascular Circulation MeSH
- Neuropsychological Tests MeSH
- Aged MeSH
- Ultrasonography, Doppler, Transcranial MeSH
- Breath Holding MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: Cerebral microangiopathy in Alzheimer's disease (AD) causes chronic hypoperfusion and probably accelerates neurodegenerative changes. OBJECTIVE: We hypothesize microvascular impairment could be present already in mild cognitive impairment (MCI) and can be revealed using transcranial color-coded sonography (TCCS) and the breath-holding maneuver. METHODS: Three groups of subjects (AD in the stage of dementia, MCI, and cognitively normal controls) with detailed neuropsychological testing and low cerebrovascular burden (no history of stroke, no intra- or extracranial artery stenoses, and no severe vascular lesions on brain MRI), underwent a TCCS assessment of peak systolic (PSV), mean flow (MFV), and end diastolic velocities (EDV) and resistance and pulsatility indices (RI, PI) in large intracranial vessels bilaterally. Cerebrovascular reserve capacity was assessed using the breath-holding index (BHI) in middle cerebral artery (MCA) bilaterally. The ultrasound parameters were compared between the groups, correlated with neuropsychological tests, and compared between amnestic and non-amnestic MCI subtypes. RESULTS: Fourteen AD (3 males, 67.9±11.1 years, MMSE 18.0±4.6), 24 MCI (13 males, 71.9±7.3 years, MMSE 28.0±1.6), and 24 risk factor-matched controls (14 males, 67.8±6.4 years, MMSE 29.1±1.2) were enrolled. Significant differences were found between AD and controls in MFV, EDV, RI, PI in right MCA after breath holding, in PSV, MFV, EDV in left MCA after breath holding, and in BHI on the left side. The left BHI correlated positively with verbal memory test. CONCLUSION: Results show decreased cerebrovascular reserve capacity in AD as a sign of impaired cerebral hemodynamic status without severe underlying atherosclerosis. This can be identified using TCCS and BHI.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028489
- 003
- CZ-PrNML
- 005
- 20190823101012.0
- 007
- ta
- 008
- 190813s2018 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3233/JAD-170815 $2 doi
- 035 __
- $a (PubMed)29614647
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Urbanova, Barbora Soukupova $u Department of Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic.
- 245 10
- $a Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment / $c BS. Urbanova, JP. Schwabova, H. Magerova, P. Jansky, H. Markova, M. Vyhnalek, J. Laczo, J. Hort, A. Tomek,
- 520 9_
- $a BACKGROUND: Cerebral microangiopathy in Alzheimer's disease (AD) causes chronic hypoperfusion and probably accelerates neurodegenerative changes. OBJECTIVE: We hypothesize microvascular impairment could be present already in mild cognitive impairment (MCI) and can be revealed using transcranial color-coded sonography (TCCS) and the breath-holding maneuver. METHODS: Three groups of subjects (AD in the stage of dementia, MCI, and cognitively normal controls) with detailed neuropsychological testing and low cerebrovascular burden (no history of stroke, no intra- or extracranial artery stenoses, and no severe vascular lesions on brain MRI), underwent a TCCS assessment of peak systolic (PSV), mean flow (MFV), and end diastolic velocities (EDV) and resistance and pulsatility indices (RI, PI) in large intracranial vessels bilaterally. Cerebrovascular reserve capacity was assessed using the breath-holding index (BHI) in middle cerebral artery (MCA) bilaterally. The ultrasound parameters were compared between the groups, correlated with neuropsychological tests, and compared between amnestic and non-amnestic MCI subtypes. RESULTS: Fourteen AD (3 males, 67.9±11.1 years, MMSE 18.0±4.6), 24 MCI (13 males, 71.9±7.3 years, MMSE 28.0±1.6), and 24 risk factor-matched controls (14 males, 67.8±6.4 years, MMSE 29.1±1.2) were enrolled. Significant differences were found between AD and controls in MFV, EDV, RI, PI in right MCA after breath holding, in PSV, MFV, EDV in left MCA after breath holding, and in BHI on the left side. The left BHI correlated positively with verbal memory test. CONCLUSION: Results show decreased cerebrovascular reserve capacity in AD as a sign of impaired cerebral hemodynamic status without severe underlying atherosclerosis. This can be identified using TCCS and BHI.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a Alzheimerova nemoc $x diagnostické zobrazování $x patofyziologie $7 D000544
- 650 _2
- $a mozek $x krevní zásobení $x diagnostické zobrazování $x patofyziologie $7 D001921
- 650 _2
- $a zadržování dechu $7 D062485
- 650 _2
- $a mozkový krevní oběh $7 D002560
- 650 _2
- $a kognitivní dysfunkce $x diagnostické zobrazování $x patofyziologie $7 D060825
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a hemodynamika $7 D006439
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a neuropsychologické testy $7 D009483
- 650 _2
- $a ultrasonografie dopplerovská transkraniální $7 D017585
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Schwabova, Jaroslava Paulasova $u Department of Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic.
- 700 1_
- $a Magerova, Hana $u Department of Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic.
- 700 1_
- $a Jansky, Petr $u Department of Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic.
- 700 1_
- $a Markova, Hana $u Department of Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic. International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Vyhnalek, Martin $u Department of Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic. International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Laczo, Jan $u Department of Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic. International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Hort, Jakub $u Department of Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic. International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Tomek, Ales $u Department of Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic.
- 773 0_
- $w MED00006350 $t Journal of Alzheimer's disease : JAD $x 1875-8908 $g Roč. 63, č. 2 (2018), s. 465-477
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29614647 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190823101226 $b ABA008
- 999 __
- $a ok $b bmc $g 1433638 $s 1066949
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 63 $c 2 $d 465-477 $e - $i 1875-8908 $m Journal of Alzheimer's disease $n J Alzheimers Dis $x MED00006350
- GRA __
- $a NT13319 $p MZ0
- LZP __
- $a Pubmed-20190813